Blue Water acquires sexual health drug Entadfi from Miami biopharma firm Veru


Cincinnati biopharma firm Blue Water Vaccines has acquired sexual health drug Entadfi for $100 million.

Previous Corporate Philanthropy Awards 2023: EyeCare Partners program brings vision, style to school children
Next 5 minutes with... Mark Waggoner, general manager of Commonwealth Care Alliance